RPTX

RPTX

USD

Repare Therapeutics Inc. Common Shares

$1.780-0.040 (-2.198%)

Prix en Temps Réel

Healthcare
Biotechnologie
Canada

Graphique des Prix

Loading Chart...

Métriques Clés

Métriques de Marché
Fondamentaux de l'Entreprise
Statistiques de Trading

Métriques de Marché

Ouverture

$1.820

Haut

$1.855

Bas

$1.780

Volume

0.15M

Fondamentaux de l'Entreprise

Capitalisation Boursière

76.5M

Industrie

Biotechnologie

Pays

Canada

Statistiques de Trading

Volume Moyen

0.13M

Bourse

NMS

Devise

USD

Intervalle sur 52 Semaines

Bas $0.89Actuel $1.780Haut $4.069

Actualités Connexes

Analyst Upgrades

HC Wainwright & Co. Maintains Buy on Repare Therapeutics, Lowers Price Target to $3

HC Wainwright & Co. analyst Robert Burns maintains Repare Therapeutics with a Buy and lowers the price target from $5 to $3.

Voir plus
HC Wainwright & Co. Maintains Buy on Repare Therapeutics, Lowers Price Target to $3
Analyst Upgrades

HC Wainwright & Co. Maintains Buy on Repare Therapeutics, Lowers Price Target to $3

HC Wainwright & Co. analyst Robert Burns maintains Repare Therapeutics with a Buy and lowers the price target from $5 to $3.

Voir plus
HC Wainwright & Co. Maintains Buy on Repare Therapeutics, Lowers Price Target to $3
BusinessWire

Repare Therapeutics to Present Initial Data from Phase 1 LIONS Clinical Trial at 37th AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics

Repare Therapeutics Inc. ("Repare" or the "Company") (NASDAQ:RPTX), a clinical-stage precision oncology company, today announced it will share initial topline safety, tolerability and early efficacy data from the Phase

Voir plus
Repare Therapeutics to Present Initial Data from Phase 1 LIONS Clinical Trial at 37th AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics

Restez Informé

Configurez des alertes de prix, recevez des mises à jour d'analyses IA et des actualités de marché en temps réel.